The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
I am a cardiovascular scientist and interventional cardiologist using biotechnological, molecular and cell biological methods as well as in vivo and ex vivo models to address translational research questions in the fields of inflammation, thrombosis and atherosclerosis. The aim of my research is to better understand the pathogenesis of cardiovascular disease and to develop new diagnostic and therapeutic strategies that ultimately provide direct benefits to patients.
I am a protein chemist-vascular biologist analysing structure, function and clinical role of platelet adhesion receptors regulating patho-physiological thrombus formation associated with thrombotic diseases such as heart attack and stroke.
Through this Australia Fellowship Prof Jackson aims to identify an entirely new approach to the treatment of heart attacks and stroke; namely the development of innovative blood clotting therapies that prevent the disease-causing effects of disturbed blood flow. This research program brings together a number of world class researchers at Monash University, the Walter and Eliza Hall Institute and RMIT University in Melbourne, with scientists at The Scripps Research Institute in San Diego to tackl ....Through this Australia Fellowship Prof Jackson aims to identify an entirely new approach to the treatment of heart attacks and stroke; namely the development of innovative blood clotting therapies that prevent the disease-causing effects of disturbed blood flow. This research program brings together a number of world class researchers at Monash University, the Walter and Eliza Hall Institute and RMIT University in Melbourne, with scientists at The Scripps Research Institute in San Diego to tackle this important medical problem. This unique research program aims to place Australia at the forefront of discovery and development of innovative new therapies for the treatment of heart disease and strokeRead moreRead less
I am an intensive care physician, clinician and researcher, interested in studying new therapies to improve outcomes in patienst with acute trauma, sepsis and lung injury. A main focus is independent phase 111 clinical trials in critically ill patients